NCT07893847

Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza

RecruitingPHASE2, PHASE3INTERVENTIONAL

Trial Details

Start: 2026-10-21Est. Completion: 2027-03-30

Enrollment target: 570 participants

Locations

Contact

Bronchitis, AcuteCommunity-acquired PneumoniaRespiratory Tract Infections

Children with lower respiratory tract infection (LRTI) are still often prescribed antibiotics in ways that depart from n…

Helsinki, FinlandEst. completion Dec 2029

EBVHSVVZVHPVCMV

Background: * Infections caused by viruses are common causes of illnesses: the common cold, many ear infections, sore t…

Bethesda, United States

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.